Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Improved cardiovascular outcomes with glucagon-like peptide-1 receptor agonists - what is the role of weight reduction?

Cardiovascular endocrinology & metabolism·2025

Same author

Obesity-Induced MASLD Is Reversed by Capsaicin via Hepatic TRPV1 Activation.

Current issues in molecular biology·2025

Same author

Cardiovascular Outcome Trials in Type 1 Diabetes: We Are Not There Yet.

Diabetes care·2025

Same author

Global cardiometabolic alliance: A clinical and research initiative addressing the 21st century pandemic of insulin resistance-associated disease.

Diabetes, obesity & metabolism·2025

Same author

Plain language summary about GLP-1 treatments in people with metabolic dysfunction-associated steatotic liver disease.

Postgraduate medicine·2025

Same author

Recommendations for the Management of Diabetes During Ramadan Applying the Principles of the ADA/ EASD Consensus: Update 2025.

Diabetes/metabolism research and reviews·2025

Search research articles

Related Experiment Video

Updated: May 21, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Autoimmune diabetes inflames the heart.

Robert H Eckel¹, George S Eisenbarth

¹Division of Endocrinology, Metabolism and Diabetes, Barbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. robert.eckel@ucdenver.edu

Science Translational Medicine

|June 16, 2012

Summary

Patients with type 1 diabetes experience ongoing heart tissue inflammation following a heart attack. This persistent cardiac inflammation poses a significant risk for cardiovascular complications in diabetic individuals.

More Related Videos

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

Related Experiment Videos

Last Updated: May 21, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

Area of Science:

Cardiology
Endocrinology
Immunology

Background:

Type 1 diabetes is a chronic condition affecting blood sugar regulation.
Myocardial infarction (heart attack) can trigger inflammatory responses in cardiac tissue.
Diabetic patients often exhibit heightened inflammatory states.

Purpose of the Study:

To investigate the prevalence and persistence of cardiac inflammation post-myocardial infarction in type 1 diabetes patients.
To understand the link between type 1 diabetes and sustained cardiac inflammation after a heart attack.

Main Methods:

Utilizing advanced cardiac imaging techniques to assess myocardial inflammation.
Analyzing inflammatory biomarkers in blood samples.
Comparing inflammation levels in type 1 diabetes patients versus control groups after myocardial infarction.

Main Results:

Type 1 diabetes patients demonstrated significantly higher and more persistent cardiac inflammation compared to non-diabetic individuals after a heart attack.
Elevated levels of specific inflammatory markers were observed in the diabetic cohort.

Conclusions:

Type 1 diabetes exacerbates and prolongs cardiac inflammation following a heart attack.
This persistent inflammation may contribute to adverse cardiac remodeling and poorer outcomes in diabetic patients.